This review aims to summarize evidence regarding the clinical and cost-effectiveness, as well as guidelines for the use of lanreotide autogel in the treatment of neuroendocrine tumors (NETs) in adult patients.
https://ift.tt/2N1XTtj
Τετάρτη 27 Ιουνίου 2018
Lanreotide for the Treatment of Neuroendocrine Tumours: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines [Internet].
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Summary Insulinomas are rare neuroendocrine tumours that classically present with fasting hypoglycaemia. This case report discusses an un...
-
The online platform for Taylor & Francis Online content New for Canadian Journal of Remote Sen...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου